0001104659-22-042813.txt : 20220405 0001104659-22-042813.hdr.sgml : 20220405 20220405164600 ACCESSION NUMBER: 0001104659-22-042813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220401 FILED AS OF DATE: 20220405 DATE AS OF CHANGE: 20220405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENTSUR RON CENTRAL INDEX KEY: 0001251213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41264 FILM NUMBER: 22807695 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVE STREET 2: 20TH FL CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvectis Pharma, Inc. CENTRAL INDEX KEY: 0001875558 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862405608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 BUSINESS PHONE: 360-837-7232 MAIL ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 4 1 tm2211420-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-04-01 0 0001875558 Nuvectis Pharma, Inc. NVCT 0001251213 BENTSUR RON C/O NUVECTIS PHARMA, INC., 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 1 1 1 0 Chairman & CEO Common Stock 2022-04-01 4 A 0 120000 0 A 2945459 D The restricted stock units will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025. Includes 96,759 shares of restricted stock and 120,000 restricted stock units. /s/ Ron Bentsur 2022-04-05